HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice

Journal of Neuroimmunology

Volumn 169, Issue 1-2, 2005, Pages 1-12

  Khare, Meenakshi ^a   Mangalam, Ashutosh ^a   Rodriguez, Moses ^a   David, Chella S ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

EAE MS; HLA class II; Myelin oligodendrocyte glycoprotein; Pathogenesis; Transgenic

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; RECOMBINANT PROTEIN;

ALLELE; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; COMPARATIVE STUDY; CONTROLLED STUDY; DEMYELINATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; BRAIN; CELL PROLIFERATION; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENES, MHC CLASS II; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; INTERFERON TYPE II; INTERLEUKIN-4; MICE; MICE, TRANSGENIC; MYELIN-ASSOCIATED GLYCOPROTEIN; SPINAL CORD; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES; TIME FACTORS;

EID: 27344459905     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.07.023     Document Type: Article

References (47)

1. C. Alvarado-de la Barrera, J. Zuniga-Ramos, J.A. Ruiz-Morales, B. Estanol, J. Granados, and L. Llorente HLA class II genotypes in Mexican mestizos with familial and nonfamilial multiple sclerosis Neurology 55 2000 1897 1900
2. S. Amor, N. Groome, C. Linington, M.M. Morris, K. Dornmair, M.V. Gardinier, J.M. Matthieu, and D. Baker Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice J. Immunol. 153 1994 4349 4356
3. U. Brehm, S.J. Piddlesden, M.V. Gardinier, and C. Linington Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG) J. Neuroimmunol. 97 1999 9 15
4. P. Das, K.M. Drescher, A. Geluk, D.S. Bradley, M. Rodriguez, and C.S. David Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitis Hum. Immunol. 61 2000 279 289
5. P. Diaz-Villoslada, A. Shih, L. Shao, C.P. Genain, and S.L. Hauser Autoreactivity to myelin antigens: myelin/oligodendrocyte glycoprotein is a prevalent autoantigen J. Neuroimmunol. 99 1999 36 43
6. K.M. Drescher, P.D. Murray, C.S. David, L.R. Pease, and M. Rodriguez CNS cell populations are protected from virus-induced pathology by distinct arms of the immune system Brain Pathol. 9 1999 21 31
7. G.C. Ebers, and A.D. Sadovnick Association studies in multiple sclerosis J. Neuroimmunol. 53 1994 117 122
8. T.P. Finn, R.E. Jones, C. Rich, R. Dahan, J. Link, C.S. David, Y.K. Chou, H. Offner, and A.A. Vandenbark HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes J. Neurosci. Res. 78 2004 100 114
9. T.G. Forsthuber, C.L. Shive, W. Wienhold, K. de Graaf, E.G. Spack, R. Sublett, A. Melms, J. Kort, M.K. Racke, and R. Weissert T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells J. Immunol. 167 2001 7119 7125
10. C.P. Genain, N.M. Letvin NL, R. Pearl, R.L. Davis, M. Adelman, M.B. Lees, C. Linington, and S.L. Hauser Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate J. Clin. Invest. 96 1995 2966 2974
11. C.P. Genain, B. Cannella, S.L. Hauser, and C.S. Raine Identification of autoantibodies associated with myelin damage in multiple sclerosis Nat. Med. 5 1999 170 175
12. M. Giordano, S. D'Alfonso, and P. Momigliano-Richiardi Genetics of multiple sclerosis: linkage and association studies Am. J. Pharmacogenomics 2 2002 37 58
13. R. Gold, H.P. Hartung, and K.V. Toyka Animal models for autoimmune demyelinating disorders of the nervous system Mol. Med. Today 6 2000 88 91
14. C.G. Haase, and S. Schmidt Detection of brain-specific autoantibodies to myelin oligodendrocyte glycoprotein, S100beta and myelin basic protein in patients with Devic's neuromyelitis optica Neurosci. Lett. 307 2001 131 133
15. J.L. Haines, Y. Bradford, M.E. Garcia, A.D. Reed, E. Neumeister, M.A. Pericak-Vance, J.B. Rimmler, M.M. Menold, E.R. Martin, J.R. Oksenberg, L.F. Barcellos, R. Lincoln, and S.L. Hauser Multiple susceptibility loci for multiple sclerosis Hum. Mol. Genet. 11 2002 2251 2256
16. S.L. Hauser, E. Fleischnick, H.L. Weiner, D. Marcus, Z. Awdeh, E.J. Yunis, and C.A. Alper Extended major histocompatibility complex haplotypes in patients with multiple sclerosis Neurology 39 1989 275 277
17. N. Hellings, M. Baree, C. Verhoeven, M.B. D'Hooghe M, R. Medaer, C.C. Bernard, J. Raus, and P. Stinissen T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls J. Neurosci. Res. 63 2001 290 302
18. N. Hellings, J. Raus, and P. Stinissen Insights into the immunopathogenesis of multiple sclerosis Immunol. Res. 25 2002 27 51
19. A. Iglesias, J. Bauer, T. Litzenburger, A. Schubart, and C. Linington T-and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis Glia 36 2001 220 234
20. A.J. Johnson, J. Upshaw, K.D. Pavelko, M. Rodriguez, and L.R. Pease Preservation of motor function by inhibition of CD8+ virus peptide-specific T cells in Theiler's virus infection FASEB J. 15 2001 2760 2762
21. S. Kankonkar, G. Jeyanti, B.S. Singhal, and U. Shankarkumar Evidence for novel DRB1*15 allele association among clinically definite multiple sclerosis patients from Mumbai, India Hum. Immunol. 64 2003 478 482
22. K. Kawamura, T. Yamamura, K. Yokoyama, D. Chui, Y. Fukui, T. Sasazuki, H. Inoko, C.S. David, and T. Tabira HLA-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice J. Clin. Invest. 105 2000 977 984
23. N. Kerlero de Rosbo, R. Milo, M.B. Lees, D. Burger, C.C. Bernard, and A. Ben-Nun Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein J. Clin. Invest. 92 1993 2602 2608
24. N. Kerlero de Rosbo, M. Hoffman, I. Mendel, I. Yust, J. Kaye, R. Bakimer, S. Flechter, O. Abramsky, R. Milo, A. Karni, and A. Ben-Nun Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions Eur. J. Immunol. 27 1997 3059 3069
25. M. Khare, M. Rodriguez, and C.S. David HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesis Int. Immunol. 15 2003 535 546
26. C.J. Krco, T.G. Beito, and C.S. David Determination of tolerance to self E alpha peptides by clonal elimination of H-2E reactive T cells and antigen presentation by H-2A molecules Transplantation 54 1992 920 923
27. O.J. Kwon, A. Karni, S. Israel, C. Brautbar, A. Amar, Z. Meiner, O. Abramsky, and D. Karussis HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews Arch. Neurol. 56 1999 555 560
28. R.B. Lindert, C.G. Haase, U. Brehm, C. Linington, H. Wekerle, and R. Hohlfeld Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein Brain 122 Pt 11 1999 2089 2100
29. C. Linington, M. Bradl, H. Lassmann, C. Brunner, and K. Vass Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein Am. J. Pathol. 130 1988 443 454
30. C. Lucchinetti, W. Bruck, J. Parisi, B. Scheithauer, M. Rodriguez, and H. Lassmann Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination Ann. Neurol. 47 2000 707 717
31. M.G. Marrosu, M.R. Murru, G. Costa, F. Cucca, S. Sotgiu, G. Rosati, and F. Muntoni Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles Am. J. Hum. Genet. 61 1997 454 457
32. R. Martin, H.F. McFarland, and D.E. McFarlin Immunological aspects of demyelinating diseases Annu. Rev. Immunol. 10 1992 153 187
33. M.M. Morris, S. Piddlesden, N. Groome, and S. Amor Anti-myelin antibodies modulate experimental allergic encephalomyelitis in Biozzi ABH mice Biochem. Soc. Trans. 25 1997 168S
34. Y. Okuda, S. Sakoda, C.C. Bernard, and T. Yanagihara The development of autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein is associated with an upregulation of both proinflammatory and immunoregulatory cytokines in the central nervous system J. Interferon Cytokine Res. 18 1998 415 421
35. O. Olerup, and J. Hillert HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation Tissue Antigens 38 1991 1 15
36. C.S. Raine, B. Cannella, S.L. Hauser, and C.P. Genain Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation Ann. Neurol. 46 1999 144 160
37. M. Reindl, C. Linington, U. Brehm, R. Egg, E. Dilitz, F. Deisenhammer, W. Poewe, and T. Berger Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study Brain 122 Pt 11 1999 2047 2056
38. G. Saruhan-Direskeneli, S. Esin, B. Baykan-Kurt, I. Ornek, R. Vaughan, and M. Eraksoy HLA-DR and -DQ associations with multiple sclerosis in Turkey Hum. Immunol. 55 1997 59 65
39. S.W. Sejeanston, X. Gao, B.R. Hawkins, D.A. Higgins, and Y.L. Yu Novel HLA-DR2-related haplotypes in Hong Kong Chinese implicate the DQB1*0602 allele in susceptibility to multiple sclerosis Eur. J. Immunogenet. 19 1992 11 19
40. A. Spurkland, K.S. Ronningen, B. Vandvik, E. Thorsby, and F. Vartdal HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis Hum. Immunol. 30 1991 69 75
41. A. Spurkland, E.G. Celius, I. Knutsen, A. Beiske, E. Thorby, and F. Vartdal The HLA-DQ (alpha1*0102, beta 1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR (alpha1*01, beta 1*1501) heterodimer Tissue Antigens 50 1997 15 22
42. L. Steinman Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system Cell 85 1996 299 302
43. J. Sun, H. Link, T. Olsson, B.G. Xiao, G. Andersson, H.P. Ekre, C. Linington, and P. Diener T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis J. Immunol. 146 1991 1490 1495
44. B.A. t Hart, H.P. Brok, S. Amor, and R.E. Bontrop The major histocompatibility complex influences the ethiopathogenesis of MS-like disease in primates at multiple levels Hum. Immunol. 62 2001 1371 1381
45. A.A. Vandenbark, C. Rich, J. Mooney, A. Zamora, C. Wang, J. Huan, L. Fugger, H. Offner, R. Jones, and G.G. Burrows Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice J. Immunol. 171 2003 127 133
46. E. Wallstrom, M. Khademi, M. Andersson, R. Weissert, C. Linington, and T. Olsson Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2 (15)+ multiple sclerosis Eur. J. Immunol. 28 1998 3329 3335
47. R. Weissert, E. Wallstrom, M.K. Storch, A. Stefferl, J. Lorentzen, H. Lassmann, C. Linington, and T. Olsson MHC haplotype-dependent regulation of MOG-induced EAE in rats J. Clin. Invest. 102 1998 1265 1273